Short Interest in 111, Inc. Sponsored ADR (NASDAQ:YI) Drops By 57.5%

111, Inc. Sponsored ADR (NASDAQ:YI) saw a significant decline in short interest in the month of May. As of May 29th, there was short interest totaling 6,011 shares, a decline of 57.5% from the May 14th total of 14,127 shares. Based on an average trading volume of 21,907 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.1% of the shares of the company are sold short.

111 Stock Down 1.8%

YI stock opened at $4.28 on Friday. The company has a market capitalization of $37.62 million, a P/E ratio of -3.06 and a beta of 0.60. The company has a 50-day simple moving average of $5.95 and a 200 day simple moving average of $5.64. 111 has a fifty-two week low of $2.48 and a fifty-two week high of $11.17.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 4th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, 111 presently has a consensus rating of “Sell”.

Insiders Place Their Bets

In related news, Director Jian David Sun sold 115,440 shares of the company’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $0.22, for a total value of $25,396.80. Following the completion of the sale, the director owned 583,111 shares of the company’s stock, valued at $128,284.42. This represents a 16.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 331,720 shares of company stock valued at $80,427 over the last three months. Corporate insiders own 43.90% of the company’s stock.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.